Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Shares Traded Last Trade
  69.00 0.91% 7,661.00 363,108 11:31:31
Bid Price Offer Price High Price Low Price Open Price
7,661.00 7,663.00 7,691.00 7,563.00 7,588.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18,386.37 1,167.24 77.67 101.1 100,505
Last Trade Time Trade Type Trade Size Trade Price Currency
11:31:31 O 2 7,661.00 GBX

Astrazeneca (AZN) Latest News (7)

More Astrazeneca News
Astrazeneca Investors    Astrazeneca Takeover Rumours
Smart Money!
AZN is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 EP GLOBAL OPPORTUNITIES TRUST PLC 2.30% 2020-11-30
 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC 5.70% 2021-04-30
 BMO CAPITAL AND INCOME INVESTMENT TRUST PLC 3.20% 2020-11-30
 JUPITER UK GROWTH INVESTMENT TRUST PLC 4.00% 2020-12-31

Astrazeneca (AZN) Discussions and Chat

Astrazeneca Forums and Chat

Date Time Title Posts
18/1/202100:15AstraZeneca3,693
22/11/202020:10Alzheimer's can be caught .... It's a transmissible disease116
22/10/202008:46*** AstraZeneca *** 365
01/5/201918:48why the fall-
13/2/201911:48AstraZeneca Full Year Results on Thursday-

Add a New Thread

Astrazeneca (AZN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:31:317,661.002153.22O
11:31:247,661.00352,681.35AT
11:31:247,661.007536.27AT
11:31:247,661.00312,374.91AT
11:31:247,661.00816,205.41AT
View all Astrazeneca trades in real-time

Astrazeneca (AZN) Top Chat Posts

DateSubject
18/1/2021
08:20
Astrazeneca Daily Update: Astrazeneca Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 7,592p.
Astrazeneca Plc has a 4 week average price of 7,196p and a 12 week average price of 7,196p.
The 1 year high share price is 10,120p while the 1 year low share price is currently 5,871p.
There are currently 1,311,904,600 shares in issue and the average daily traded volume is 3,273,673 shares. The market capitalisation of Astrazeneca Plc is £100,793,630,418.
01/1/2021
09:46
beckers2008: Montyhedge, I repeat... You always spout on the AZN BB when the share price is taking a turn for the worse, that's why I got emotional, certainly not losing money on AZN! Leave this BB and stick to the BB's that you have holdings, if you have any?
31/12/2020
14:29
beckers2008: M, You always spout on the AZN BB when the share price is taking a turn for the worse, that's why I got emotional, certainly not losing money on AZN! Leave this BB and stick to the BB's that you have holdings, if you have any?
31/12/2020
14:10
trekker60: I go along with those who have previously suggested that while the vaccine is hopefully going to be hugely important in terms of saving lives and helping to substantially reduce the impact of the pandemic, it ultimately going to have only a limited impact on AZN's overall profitability (due to the costs involved and tight margins). So I also agree that it is likely that the proposed Alexion deal is the main drag on the share price at the moment.
30/12/2020
21:53
thaiger: Share price down due to acquisition of Alexon at too high a price and some analysts said AZN might have to pay more to clinch the deal!??!!
30/12/2020
08:23
triple witcher: Interesting reaction in the share price to this news, don't think it's a case of sell the news, however where is the next catalyst? Agreement for use of the vaccine in the US ? According to the CEO the vaccine will be shipped either today or tomorrow. This is great news for AZN so is the market once again focusing on its proposed purchase of Alexion which was the main driver of pushing down the share price ? Thoughts anybody ?
15/12/2020
19:06
buywell3: AZN threw quite a lot of news at the markets over the last couple of days imo to try to keep the share price at levels that helped the bid for Alexion buywell wonders how much more positive newsflow azn has left in the locker that can now counteract market sentiment buywell is still of the opinion that investors in the USA will have to come to terms with reality of the Global Downturn taking place and Covid-19 continuance Stimulus packages forever otherwise in a Covid-19 endemic Other actions needed see BUY Mass Testing has caused Politicians to NOT carry out National Lockdowns as it has fudged the issue with false hopes as has masks and track and trace Lack of National Lockdowns of at least 8 weeks duration or better still 12 weeks Has caused the worldwide mess we are now in ---- and getting worse buy the day Germany is locking down till Jan 10th ie not enough like Holland and the Czech Republic Italy will act later this week or else go into meltdown
14/12/2020
11:33
essentialinvestor: Unfortunately the vaccine hype train propelled AZN past £100 a share, at that price it was well ahead of fundamentals. And I'm not sure what people find difficult in understanding when AZN say...we will supply our vaccine at cost. COVID was never going to be goldmine financially. It buys some goodwill and may help with other contacts or future research. Yes AZN may be able to supply this at profit at some point, however we could have 10-15 plus competing vaccines by then. And just take a look at GSK, one of the largest vaccine makers globally, their share price moribund for 2 decades.
13/12/2020
16:06
steeplejack: You can never be sure with the markets.There’s a number of factors including how sterling behaves in the next few days on the latest Brexit moves.On the perceived ‘negative̵7; side acquiring Alexion will make AZN pretty immune to takeover so the “Pfizer bid factor” will be a thing of the past.It is already really.The level of debt which the group is taking on will be of concern and the prospect that Alexion shareholders might decide to sell the AZN shares they receive albeit those concerns are nine months away when the deal completes.Really,it’s a question of whether you trust the managements judgement.If the market considers that the AZNs assumption of a 10% earnings accretive deal over a three year period to be erroneous,the shares will fall by perhaps £5 but if they accept the board’s rationale,the price will react favourably.The Alexion share price has been dull of late suggesting the market had not got wind of AZNs intentions but I suspect,ever since the Gilead discussions,the prospect of AZN making a corporate move has been anticipated.Whether a move of this description was ‘discounted217; ,we’ll find out tomorrow.If you don’t trust the board to make a good acquisition,then you shouldn’t be in the shares,it’s as simple as that.
13/12/2020
11:24
steeplejack: "Much of the public attention that AstraZeneca has received recently has surrounded its Covid-19 vaccine candidate, but it is unlikely to be a significant part of company sales for a long time. Alexion is far more material. AstraZeneca expects the deal to increase earnings per share by at least 10% over the next three years. The company also said that the acquisition "supports" its "progressive dividend policy," signaling a higher payout eventually."The AZN price is likely to go up.The deal would be earnings accretive and even if a third party gate crashes the party,there's a break fee of over a billion that could come Astra's way..
23/11/2020
08:17
netcurtains: OXB up - so the market is probably impressed but some of the good news probably already factored into AZN price?
Astrazeneca share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210118 11:46:36